Curosurf 1.5Ml/80Mg Inj

Curosurf 1.5Ml/80Mg Inj belongs to a class of drugs called pulmonary surfactants. It is used to treat premature infants suffering from or at risk of a condition called respiratory distress syndrome (RDS). Respiratory distress syndrome, or RDS, is caused by insufficient surfactant in the lungs.

Curosurf 1.5Ml/80Mg Inj contains Poractant Alfa, a natural surfactant that works in the same way as human surfactant. It will help your baby breathe normally until it produces its own surfactant.

Curosurf 1.5Ml/80Mg Inj will be given to your baby in a hospital by a suitably trained doctor. In some cases, Curosurf 1.5Ml/80Mg Inj may cause a slow heart rate, low blood pressure, endotracheal tube blockage, and low blood oxygen levels.

The administration of Curosurf 1.5Ml/80Mg Inj to your newborn may impair your baby's lungs' ability to absorb oxygen. As a result, your baby will be closely monitored by a nurse or doctor so that oxygen and ventilatory support can be adjusted as needed. If your baby has any problems while being treated with Curosurf 1.5Ml/80Mg Inj, consult your doctor as soon as possible, even if you do not know the condition is related to the medicine.

Curosurf 1.5Ml/80Mg Inj is a pulmonary surfactant. It is used to treat premature infants who have or are at risk of developing respiratory distress syndrome (RDS). Curosurf 1.5Ml/80Mg Inj contains Poractant Alfa, a natural surfactant that works similarly to human surfactant. As a result, it will assist your baby in breathing normally until they develop their own surfactant.

Before using Curosurf 1.5Ml/80Mg Inj, let your doctor know about all your children's medical conditions, sensitivities, and all medications used. The administration of Curosurf 1.5Ml/80Mg Inj to your newborn may impair your baby's lungs' ability to absorb oxygen. As a result, your baby will be closely monitored by a nurse or doctor so that oxygen and ventilatory support can be adjusted as needed. If your baby experiences any issues while being treated with Curosurf 1.5Ml/80Mg Inj, contact your doctor as soon as possible, even if you do not feel the problem is due to the medication.

NA

Respiratory distress syndrome (RDS):  RDS is mainly caused when the baby's lungs do not have enough surfactant. The earlier the infant is born, the more probable they may have RDS. Under such conditions, the baby requires extra oxygen, which is done through ventilatory support.